"High plasma levels of C1-inhibitor are associated with lower risk of future venous thromboembolism": comment from Tanaka et al

J Thromb Haemost. 2023 Oct;21(10):2991-2992. doi: 10.1016/j.jtha.2023.06.037.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Complement C1 Inhibitor Protein*
  • Humans
  • Venous Thromboembolism* / diagnosis
  • Venous Thromboembolism* / drug therapy

Substances

  • Complement C1 Inhibitor Protein